![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis...
Genentech, Inc., a member of the Roche Group, and Biogen Idec announced 24-week results1 from...
21-Year Long-term Follow-up Study Demonstrates Significant Survival Advantage with Betaferon Treatment
New findings from the longest assessment of any MS-specific treatment show that patients treated earlier...
Sanofi-aventis announced the results from the two year phase III TEMSO study of teriflunomide
Sanofi-aventis announced the results from the two year phase III TEMSO study of teriflunomide, a...
Novartis Phase III study of Afinitor® plus Sandostatin® LAR® in patients with advanced neuroendocrine...
A Novartis Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR® (octreotide...
Afatinib (BIBW 2992*) triples progression free survival in phase III study in lung cancer...
Boehringer Ingelheim announced today promising results from two clinical trials of its investigational cancer compound...
The GRACE study has significant implications for inclusion of women in clinical trials
Data from the GRACE study will be published in the September 21st issue of the...
Novartis study shows Onbrez® Breezhaler® is superior to salmeterol in reducing breathlessness for patients...
Results of the Phase III INSIST study show that Onbrez® Breezhaler® (indacaterol) given once-daily is...
Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic...
A new genetic substudy of PLATO showed that the effects on a combined primary endpoint...
New Study Reinforces Safety Profile of GARDASIL®, the Cervical Cancer Vaccine
Merck introduced GARDASIL® , the world's first cervical cancer vaccine, a vaccine that can also...
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced final results from a retrospective...
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced final results from a retrospective study...